Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Adaptive Neuromodulation Therapy Devices Market Research Report 2026
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-15
Pages: 90 Pages
Report ld: 5668381
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Adaptive Neuromodulation Therapy Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Adaptive Neuromodulation Therapy Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
The North American market for Adaptive Neuromodulation Therapy Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Adaptive Neuromodulation Therapy Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Adaptive Neuromodulation Therapy Devices include Medtronic plc, Amber Therapeutics, Newronika SPA, Genlight, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Adaptive Neuromodulation Therapy Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Adaptive Neuromodulation Therapy Devices. The Adaptive Neuromodulation Therapy Devices market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Adaptive Neuromodulation Therapy Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Adaptive Neuromodulation Therapy Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Medtronic plc
- Amber Therapeutics
- Newronika SPA
- Genlight
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single-channel
- Dual Channels
Segment by Application
- Epilepsy
- Parkinson's Disease (PD)
- Mixed urinary incontinence (MUI)
- Other
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Adaptive Neuromodulation Therapy Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Adaptive Neuromodulation Therapy Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Adaptive Neuromodulation Therapy Devices Market Overview
1.1 Product Definition
1.2 Adaptive Neuromodulation Therapy Devices by Type
1.2.1 Global Adaptive Neuromodulation Therapy Devices Market Value by Type: 2025 vs 2032
1.2.2 Single-channel
1.2.3 Dual Channels
1.3 Adaptive Neuromodulation Therapy Devices by Application
1.3.1 Global Adaptive Neuromodulation Therapy Devices Market Value by Application: 2025 vs 2032
1.3.2 Epilepsy
1.3.3 Parkinson's Disease (PD)
1.3.4 Mixed urinary incontinence (MUI)
1.3.5 Other
1.4 Global Adaptive Neuromodulation Therapy Devices Market Size Estimates and Forecasts
1.4.1 Global Adaptive Neuromodulation Therapy Devices Revenue 2021–2032
1.4.2 Global Adaptive Neuromodulation Therapy Devices Sales 2021–2032
1.4.3 Global Adaptive Neuromodulation Therapy Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Adaptive Neuromodulation Therapy Devices Market Competition by Manufacturers
2.1 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Adaptive Neuromodulation Therapy Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Adaptive Neuromodulation Therapy Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Product Types and Applications
2.7 Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Date of Entry into the Industry
2.8 Global Adaptive Neuromodulation Therapy Devices Market Competitive Situation and Trends
2.8.1 Global Adaptive Neuromodulation Therapy Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Adaptive Neuromodulation Therapy Devices Players Market Share by Revenue
2.8.3 Global Adaptive Neuromodulation Therapy Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adaptive Neuromodulation Therapy Devices Market Scenario by Region
3.1 Global Adaptive Neuromodulation Therapy Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Adaptive Neuromodulation Therapy Devices Sales by Region: 2021–2032
3.2.1 Global Adaptive Neuromodulation Therapy Devices Sales by Region: 2021–2026
3.2.2 Global Adaptive Neuromodulation Therapy Devices Sales by Region: 2027–2032
3.3 Global Adaptive Neuromodulation Therapy Devices Revenue by Region: 2021–2032
3.3.1 Global Adaptive Neuromodulation Therapy Devices Revenue by Region: 2021–2026
3.3.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Region: 2027–2032
3.4 North America Adaptive Neuromodulation Therapy Devices Market Facts & Figures by Country
3.4.1 North America Adaptive Neuromodulation Therapy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Adaptive Neuromodulation Therapy Devices Sales by Country (2021–2032)
3.4.3 North America Adaptive Neuromodulation Therapy Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adaptive Neuromodulation Therapy Devices Market Facts & Figures by Country
3.5.1 Europe Adaptive Neuromodulation Therapy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Adaptive Neuromodulation Therapy Devices Sales by Country (2021–2032)
3.5.3 Europe Adaptive Neuromodulation Therapy Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adaptive Neuromodulation Therapy Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Adaptive Neuromodulation Therapy Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Adaptive Neuromodulation Therapy Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Adaptive Neuromodulation Therapy Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adaptive Neuromodulation Therapy Devices Market Facts & Figures by Country
3.7.1 Latin America Adaptive Neuromodulation Therapy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Adaptive Neuromodulation Therapy Devices Sales by Country (2021–2032)
3.7.3 Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Adaptive Neuromodulation Therapy Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Adaptive Neuromodulation Therapy Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Adaptive Neuromodulation Therapy Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Adaptive Neuromodulation Therapy Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adaptive Neuromodulation Therapy Devices Sales by Type (2021–2032)
4.1.1 Global Adaptive Neuromodulation Therapy Devices Sales by Type (2021–2026)
4.1.2 Global Adaptive Neuromodulation Therapy Devices Sales by Type (2027–2032)
4.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Type (2021–2032)
4.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Type (2021–2032)
4.2.1 Global Adaptive Neuromodulation Therapy Devices Revenue by Type (2021–2026)
4.2.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Type (2027–2032)
4.2.3 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Type (2021–2032)
4.3 Global Adaptive Neuromodulation Therapy Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Adaptive Neuromodulation Therapy Devices Sales by Application (2021–2032)
5.1.1 Global Adaptive Neuromodulation Therapy Devices Sales by Application (2021–2026)
5.1.2 Global Adaptive Neuromodulation Therapy Devices Sales by Application (2027–2032)
5.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Application (2021–2032)
5.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Application (2021–2032)
5.2.1 Global Adaptive Neuromodulation Therapy Devices Revenue by Application (2021–2026)
5.2.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Application (2027–2032)
5.2.3 Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Application (2021–2032)
5.3 Global Adaptive Neuromodulation Therapy Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Company Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Adaptive Neuromodulation Therapy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic plc Adaptive Neuromodulation Therapy Devices Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Amber Therapeutics
6.2.1 Amber Therapeutics Company Information
6.2.2 Amber Therapeutics Description and Business Overview
6.2.3 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Product Portfolio
6.2.5 Amber Therapeutics Recent Developments/Updates
6.3 Newronika SPA
6.3.1 Newronika SPA Company Information
6.3.2 Newronika SPA Description and Business Overview
6.3.3 Newronika SPA Adaptive Neuromodulation Therapy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Newronika SPA Adaptive Neuromodulation Therapy Devices Product Portfolio
6.3.5 Newronika SPA Recent Developments/Updates
6.4 Genlight
6.4.1 Genlight Company Information
6.4.2 Genlight Description and Business Overview
6.4.3 Genlight Adaptive Neuromodulation Therapy Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Genlight Adaptive Neuromodulation Therapy Devices Product Portfolio
6.4.5 Genlight Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adaptive Neuromodulation Therapy Devices Industry Chain Analysis
7.2 Adaptive Neuromodulation Therapy Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adaptive Neuromodulation Therapy Devices Production Mode & Process Analysis
7.4 Adaptive Neuromodulation Therapy Devices Sales and Marketing
7.4.1 Adaptive Neuromodulation Therapy Devices Sales Channels
7.4.2 Adaptive Neuromodulation Therapy Devices Distributors
7.5 Adaptive Neuromodulation Therapy Devices Customer Analysis
8 Adaptive Neuromodulation Therapy Devices Market Dynamics
8.1 Adaptive Neuromodulation Therapy Devices Industry Trends
8.2 Adaptive Neuromodulation Therapy Devices Market Drivers
8.3 Adaptive Neuromodulation Therapy Devices Market Challenges
8.4 Adaptive Neuromodulation Therapy Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Adaptive Neuromodulation Therapy Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Adaptive Neuromodulation Therapy Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Adaptive Neuromodulation Therapy Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Adaptive Neuromodulation Therapy Devices Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Adaptive Neuromodulation Therapy Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Adaptive Neuromodulation Therapy Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Adaptive Neuromodulation Therapy Devices Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Adaptive Neuromodulation Therapy Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Adaptive Neuromodulation Therapy Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adaptive Neuromodulation Therapy Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adaptive Neuromodulation Therapy Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adaptive Neuromodulation Therapy Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Adaptive Neuromodulation Therapy Devices Sales by Region (Units), 2021–2026
Table 18. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Region (2021–2026)
Table 19. Global Adaptive Neuromodulation Therapy Devices Sales by Region (Units), 2027–2032
Table 20. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Region (2027–2032)
Table 21. Global Adaptive Neuromodulation Therapy Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Adaptive Neuromodulation Therapy Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Adaptive Neuromodulation Therapy Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2021–2026
Table 27. North America Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2027–2032
Table 28. North America Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Adaptive Neuromodulation Therapy Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2021–2026
Table 32. Europe Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2027–2032
Table 33. Europe Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Adaptive Neuromodulation Therapy Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Adaptive Neuromodulation Therapy Devices Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Adaptive Neuromodulation Therapy Devices Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Adaptive Neuromodulation Therapy Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Adaptive Neuromodulation Therapy Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2021–2026
Table 42. Latin America Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2027–2032
Table 43. Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Adaptive Neuromodulation Therapy Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Adaptive Neuromodulation Therapy Devices Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Adaptive Neuromodulation Therapy Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Adaptive Neuromodulation Therapy Devices Sales (Units) by Type (2021–2026)
Table 51. Global Adaptive Neuromodulation Therapy Devices Sales (Units) by Type (2027–2032)
Table 52. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Type (2021–2026)
Table 53. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Type (2027–2032)
Table 54. Global Adaptive Neuromodulation Therapy Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Adaptive Neuromodulation Therapy Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Type (2021–2026)
Table 59. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Type (2027–2032)
Table 60. Global Adaptive Neuromodulation Therapy Devices Sales (Units) by Application (2021–2026)
Table 61. Global Adaptive Neuromodulation Therapy Devices Sales (Units) by Application (2027–2032)
Table 62. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Application (2021–2026)
Table 63. Global Adaptive Neuromodulation Therapy Devices Sales Market Share by Application (2027–2032)
Table 64. Global Adaptive Neuromodulation Therapy Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Adaptive Neuromodulation Therapy Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Application (2021–2026)
Table 69. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Application (2027–2032)
Table 70. Medtronic plc Company Information
Table 71. Medtronic plc Description and Business Overview
Table 72. Medtronic plc Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 73. Medtronic plc Adaptive Neuromodulation Therapy Devices Product
Table 74. Medtronic plc Recent Developments/Updates
Table 75. Amber Therapeutics Company Information
Table 76. Amber Therapeutics Description and Business Overview
Table 77. Amber Therapeutics Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 78. Amber Therapeutics Adaptive Neuromodulation Therapy Devices Product
Table 79. Amber Therapeutics Recent Developments/Updates
Table 80. Newronika SPA Company Information
Table 81. Newronika SPA Description and Business Overview
Table 82. Newronika SPA Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 83. Newronika SPA Adaptive Neuromodulation Therapy Devices Product
Table 84. Newronika SPA Recent Developments/Updates
Table 85. Genlight Company Information
Table 86. Genlight Description and Business Overview
Table 87. Genlight Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 88. Genlight Adaptive Neuromodulation Therapy Devices Product
Table 89. Genlight Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Adaptive Neuromodulation Therapy Devices Distributors List
Table 93. Adaptive Neuromodulation Therapy Devices Customers List
Table 94. Adaptive Neuromodulation Therapy Devices Market Trends
Table 95. Adaptive Neuromodulation Therapy Devices Market Drivers
Table 96. Adaptive Neuromodulation Therapy Devices Market Challenges
Table 97. Adaptive Neuromodulation Therapy Devices Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adaptive Neuromodulation Therapy Devices
Figure 2. Global Adaptive Neuromodulation Therapy Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Adaptive Neuromodulation Therapy Devices Market Share by Type: 2025 & 2032
Figure 4. Single-channel Product Picture
Figure 5. Dual Channels Product Picture
Figure 6. Global Adaptive Neuromodulation Therapy Devices Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Adaptive Neuromodulation Therapy Devices Market Share by Application: 2025 & 2032
Figure 8. Epilepsy
Figure 9. Parkinson's Disease (PD)
Figure 10. Mixed urinary incontinence (MUI)
Figure 11. Other
Figure 12. Global Adaptive Neuromodulation Therapy Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Adaptive Neuromodulation Therapy Devices Market Size (US$ Million), 2021–2032
Figure 14. Global Adaptive Neuromodulation Therapy Devices Sales (Units), 2021–2032
Figure 15. Global Adaptive Neuromodulation Therapy Devices Average Price (K US$/Unit), 2021–2032
Figure 16. Adaptive Neuromodulation Therapy Devices Report Years Considered
Figure 17. Adaptive Neuromodulation Therapy Devices Sales Share by Manufacturers in 2025
Figure 18. Global Adaptive Neuromodulation Therapy Devices Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Adaptive Neuromodulation Therapy Devices Players: Market Share by Revenue in Adaptive Neuromodulation Therapy Devices in 2025
Figure 20. Adaptive Neuromodulation Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Adaptive Neuromodulation Therapy Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Adaptive Neuromodulation Therapy Devices Sales Market Share by Country (2021–2032)
Figure 23. North America Adaptive Neuromodulation Therapy Devices Revenue Market Share by Country (2021–2032)
Figure 24. United States Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Adaptive Neuromodulation Therapy Devices Sales Market Share by Country (2021–2032)
Figure 27. Europe Adaptive Neuromodulation Therapy Devices Revenue Market Share by Country (2021–2032)
Figure 28. Germany Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Adaptive Neuromodulation Therapy Devices Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Adaptive Neuromodulation Therapy Devices Revenue Market Share by Region (2021–2032)
Figure 35. China Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Adaptive Neuromodulation Therapy Devices Sales Market Share by Country (2021–2032)
Figure 43. Latin America Adaptive Neuromodulation Therapy Devices Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Adaptive Neuromodulation Therapy Devices Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Adaptive Neuromodulation Therapy Devices Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Adaptive Neuromodulation Therapy Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Adaptive Neuromodulation Therapy Devices by Type (2021–2032)
Figure 54. Global Revenue Market Share of Adaptive Neuromodulation Therapy Devices by Type (2021–2032)
Figure 55. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Adaptive Neuromodulation Therapy Devices by Application (2021–2032)
Figure 57. Global Revenue Market Share of Adaptive Neuromodulation Therapy Devices by Application (2021–2032)
Figure 58. Global Adaptive Neuromodulation Therapy Devices Price (K US$/Unit) by Application (2021–2032)
Figure 59. Adaptive Neuromodulation Therapy Devices Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Adaptive Neuromodulation Therapy Devices market?
The top companies in the global Adaptive Neuromodulation Therapy Devices market are Medtronic plc、Amber Therapeutics、Newronika SPA.
Related Reports
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 74
USD 4250.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 122
USD 4900.00
(Single User License)
Adaptive Neuromodulation Therapy Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 87
USD 3950.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 117
USD 4900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 71
USD 4250.00
(Single User License)
Adaptive Neuromodulation Therapy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 80
USD 3950.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2025
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 77
USD 2900.00
(Single User License)
Global and United States Adaptive Neuromodulation Therapy Devices Market Report & Forecast 2024-2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 88
USD 4350.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2024
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 74
USD 2900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Insights, Forecast to 2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 119
USD 4900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 74
USD 4250.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 122
USD 4900.00 (Single User License)Adaptive Neuromodulation Therapy Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 87
USD 3950.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 117
USD 4900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 71
USD 4250.00 (Single User License)Adaptive Neuromodulation Therapy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 80
USD 3950.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Research Report 2025
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 77
USD 2900.00 (Single User License)Global and United States Adaptive Neuromodulation Therapy Devices Market Report & Forecast 2024-2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 88
USD 4350.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Research Report 2024
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 74
USD 2900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Insights, Forecast to 2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 119
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now